Trikafta 100 mg / 50 mg / 75 mg
Trikafta 100 mg / 50 mg / 75 mg is a medicine authorised by Swissmedic under authorisation number 69212. The authorisation holder is Vertex Pharmaceuticals (CH) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 13 June 2024 and the authorisation is limited until 12 June 2029. ATC code R07AX32 places the medicine in the group Other respiratory system products.
| Authorisation number | 69212 |
|---|---|
| Name | Trikafta 100 mg / 50 mg / 75 mg |
| Full name | Trikafta 100 mg / 50 mg / 75 mg, 75 mg, Granulat |
| Authorisation holder | Vertex Pharmaceuticals (CH) GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | R07AX32 |
| First authorisation | 13 June 2024 |
| Authorisation validity | 12 June 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Trikafta 100 mg / 50 mg / 75 mg, 75 mg, Granulat | A | 13 June 2024 |
| 2 | Trikafta 80 mg / 40 mg / 60 mg, 59.5 mg, Granulat | A | 13 June 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 56 | Sachet(s) | R07AX32 | 03.99.0. | A |
| 1 | 56 | Sachet(s) | R07AX32 | 03.99.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Trikafta 100 mg / 50 mg / 75 mg authorised in Switzerland?
Yes. Trikafta 100 mg / 50 mg / 75 mg is authorised by Swissmedic under authorisation number 69212, data as of 01 September 2026. The authorisation is limited until 12 June 2029.
Which dispensing category does Trikafta 100 mg / 50 mg / 75 mg have?
Trikafta 100 mg / 50 mg / 75 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Trikafta 100 mg / 50 mg / 75 mg?
The authorisation holder is Vertex Pharmaceuticals (CH) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.